Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
12 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Valmont Industries reported third-quarter net sales up 5.5% to $1.1 billion and EPS up 25.3%. It reaffirmed full-year sales guidance of $4.3 billion to $4.45 billion and raised adjusted diluted EPS guidance to $22.75 to $23.75.
Hasbro reported Q3 revenue growth of 15% and a 52% increase in adjusted operating profit, with growth across all three segments. The company raised its full-year outlook, expecting revenue growth of 7% to 9% and adjusted EBITDA of $1.575 billion to $1.625 billion.
Johnson & Johnson reported better-than-expected profit and raised its full-year outlook, while MedTech sales of $8.64 billion came in below the $8.71 billion analyst estimate. Shares fell 5.73% to $248.61.
Johnson & Johnson raises 2026 sales outlook to 6.7%-7.1% while projecting $100.7B midpoint revenue
Johnson & Johnson raised its 2026 sales outlook to $101 billion-$101.40 billion and adjusted earnings guidance to $11.05-$11.15 per share. It expects the Firefly Bio acquisition and Sail Biomedicines collaboration to reduce 2027 adjusted earnings by a combined $1.36 per share.
Johnson & Johnson reported third-quarter operational sales growth of 6% and revenue above $25 billion. The company raised its full-year 2026 operational sales growth outlook to 6.7%–7.1%.
Johnson & Johnson raised 2026 operational sales growth guidance to 6.7%-7.1%, implying USD 100.7 billion at the midpoint. Reported sales growth forecast lifted to 7.2%-7.6%, implying USD 101.2 billion at the midpoint, based on a USD 1.15 average euro rate. Adjusted operational EPS outlook set at USD 10.95-11.05; report
Goldman Sachs upgraded Palantir to buy from neutral, saying the company is positioned to benefit from growth in bespoke software and sovereign AI. The stock was up 1.6%.
B2Gold (TSX: BTO ) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary B2Gold Corporation reported consolidated gold production of appro
B2Gold (AMEX: BTG ) reported second-quarter financial results on Friday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary B2Gold Corpo
Macy's said second-quarter net sales, comparable sales, adjusted EBITDA and adjusted diluted EPS all exceeded guidance. The company reported 2.7% comparable sales growth and said adjusted EPS was 63 cents, helped by tariff refunds.
Johnson & Johnson (NYSE: JNJ ) on Wednesday reported second-quarter 2026 results that topped Wall Street estimates and raised its full-year sales and adjusted earnings guidance as strength in its Innovative Medicine and MedTech businesses offset continued pressure from several legacy products. Adjusted earnings rose 4.